Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher deFilippi

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|September 9, 2025
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIVMárton Kolossváry, Irini Sereti, Markella V Zanni, et al.
JACC. Advances|September 10, 2024
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIVChristopher deFilippi, Sara McCallum, Markella V Zanni, et al.
JAMA Network Open|February 8, 2021
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in VirginiaElizabeth T Rogawski McQuade, Kristin A Guertin, Lea Becker, et al.
European Heart Journal. Acute Cardiovascular Care|May 9, 2018
Copeptin to rule out myocardial infarction in Blacks versus CaucasiansNeil Beri, Lori B Daniels, Allan Jaffe, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
European Journal of Heart Failure|May 23, 2015
Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency MedicineAlexandre Mebazaa, M Birhan Yilmaz, Phillip Levy, et al.
The American Journal of Emergency Medicine|November 17, 2016
Necessity of hospitalization and stress testing in low risk chest pain patientsNeil Beri, Nicholas A Marston, Lori B Daniels, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 25, 2015
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trialKevin S Shah, Nicholas A Marston, Christian Mueller, et al.
Coronary Artery Disease|July 26, 2022
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndromeYu Horiuchi, Nicholas Wettersten, Mitul P Patel, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|September 9, 2025
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIVMárton Kolossváry, Irini Sereti, Markella V Zanni, et al.
JACC. Advances|September 10, 2024
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIVChristopher deFilippi, Sara McCallum, Markella V Zanni, et al.
JAMA Network Open|February 8, 2021
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in VirginiaElizabeth T Rogawski McQuade, Kristin A Guertin, Lea Becker, et al.
European Heart Journal. Acute Cardiovascular Care|May 9, 2018
Copeptin to rule out myocardial infarction in Blacks versus CaucasiansNeil Beri, Lori B Daniels, Allan Jaffe, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
European Journal of Heart Failure|May 23, 2015
Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency MedicineAlexandre Mebazaa, M Birhan Yilmaz, Phillip Levy, et al.
The American Journal of Emergency Medicine|November 17, 2016
Necessity of hospitalization and stress testing in low risk chest pain patientsNeil Beri, Nicholas A Marston, Lori B Daniels, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 25, 2015
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trialKevin S Shah, Nicholas A Marston, Christian Mueller, et al.
Coronary Artery Disease|July 26, 2022
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndromeYu Horiuchi, Nicholas Wettersten, Mitul P Patel, et al.
Pageof 12